Apple Cider Vinegar Powder

Apple cider vinegar powder reference formula at a default of 500 mg per serving, developed as a capsule or tablet.

Apple Cider Vinegar is a reference formula for brands building a single-ingredient dried apple cider vinegar product around 500 mg per serving. The brand sets the final amount for its market, and reference labels span 200 to 3,000 mg per serving.

Capsule is the lead format because most reference labels use it, with tablet developed alongside. The work centers on the powder: a dried vinegar carries residual acidity and attracts moisture, so its carrier, its acid content and the unit’s resistance to sticking and caking decide the formula.

Ingredient Composition

IngredientPer ServingRaw Material FormAlternative Form (same amount of active)
Apple Cider Vinegar500 mgDried apple cider vinegar powder, specified on a declared-weight basis; 500 mg powder per servingApple Cider Vinegar Powder from the botanicals range, with its acetic acid content and carrier named on the specification

The amount is stated as mg of dried apple cider vinegar powder, not of liquid vinegar. Dried vinegar is made by drying the liquid onto a carrier, so the specification names the carrier and the acetic acid content, and the figure here is the powder weight.

Intended Benefits & Formula Rationale

This formula is designed for products positioned around daily vinegar nutrition in a dry unit. Apple cider vinegar is included as the single ingredient so that the concept stays on one food-derived ingredient.

Intended Benefit DirectionKey IngredientsFormulation Rationale
Apple cider vinegar as a daily ingredientApple Cider VinegarA meta-analysis pooled nine studies of apple cider vinegar consumption in adults, excluding studies that combined it with other interventions [1]. Evidence: Referenced
Metabolic markersApple Cider VinegarThe same meta-analysis reports that apple cider vinegar consumption decreased serum total cholesterol, fasting plasma glucose and HbA1c, with no significant effect on LDL-C, HDL-C, fasting insulin or HOMA-IR [1]. Evidence: Mixed

The amount is a design choice. The studies in [1] used vinegar as a drink, with a subgroup analysis at 15 mL per day or less, while this formula uses dried powder at 500 mg per serving, so the review does not describe this formula and any claim on a finished product is reviewed for each market.

Available Formats

Reference labels are mostly capsules, with tablets and gummies behind them; capsule and tablet are developed here.

FormatUnitPer ServingPack SizeOther Ingredients (typical)Suitability
Capsule1 capsuleApple cider vinegar powder 500 mg60 or 120 capsulesGelatin or vegetable capsule shell, flow agentLead format; blended fill
Tablet1 tabletApple cider vinegar powder 500 mg60 or 120 tabletsMicrocrystalline cellulose, silica, magnesium stearate, coatingCompressed unit; acidity needs a coating

Raw Material Input & Fill (Design Estimate)

Design estimates. The powder is taken at its declared weight, so 500 mg per serving needs 500 mg of raw material; the supplier’s acetic acid assay is applied once the grade is chosen.

FormatRaw Material Input per UnitDesign FillBalance for ExcipientsVerification Before Scale-Up
Capsule500 mg540 mg per capsule40 mgPowder flow with moisture uptake, fill weight variation, shell compatibility with the acid, disintegration
Tablet500 mg650 mg tablet weight150 mgCompression and sticking, hardness, coating, disintegration

Gummy, powder drink and liquid are separate projects, because a vinegar powder at 500 mg per gummy needs its own acidity and pectin work, and the liquid is a different raw material.

Formulation Considerations

Residual acidity. Dried vinegar still carries acetic acid, which can attack a gelatin shell or a magnesium stearate lubricant over time. Shell type, lubricant level and a coating are tested on stability.
Moisture and caking. The carrier in the powder attracts moisture, and a damp powder cakes in the hopper and sticks to tablet punches. Moisture limits, humidity-controlled filling and a desiccant are part of the plan.
Smell and taste. The vinegar note stays in a capsule or a coated tablet. Odor in the opened bottle is considered in the pack choice.
Carrier and label. Because the powder is vinegar dried onto a carrier, the label lists the carrier and the specification states its share, which affects the amount of actual vinegar solids per serving.

Customization Options

Brands adjust the amount, the grade, the format and the add-ons.

ParameterRangeNote
Powder per serving500, 1000 or 1500 mgExamples for the brand; unit count rises with the amount
GradeBy acetic acid content and carrierChanges the fill weight and the acidity of the unit
FormatCapsule or tabletGummy, powder drink and liquid are separate projects
Add-onsChromium, green tea extractA second ingredient changes the fill weight and the blend plan

The pilot run confirms the powder flow of the chosen grade, the capsule shell integrity after a short hold, and the tablet sticking behavior.

Technical Status & Data Sources

ItemStatusDetails
Reference formulaNIH DSLDThe ingredient and amount come from a labeled product in the NIH DSLD (500 mg on the label of CF017569; example DSLD labels 221669, 284367, 306058). The label names the ingredient as apple cider vinegar; dried powder is set as the form.
SpecificationSet in formulationDried apple cider vinegar powder at 500 mg per serving; acetic acid content, carrier, moisture, microbial and heavy-metal limits and method are fixed with the supplier. Unit size, fill weight and stability are set in formulation.
Data sourceNIH DSLDDSLD v9.4.0, downloaded 2026-01-10: 50,824 reference formulas merged from on-market labels with complete ingredient amounts. Counts show how labels are distributed.
Market reviewPer marketDose limits, labeling and claims are reviewed for each sales market before a finished product is developed.
ReferencesSources[1] Hadi A, Pourmasoumi M, Najafgholizadeh A, et al. The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials. BMC Complement Med Ther. 2021;21(1):179. DOI · PubMed

Related products

OEM/ODM Development Inquiry

Essencefield supports custom supplement formulation and OEM/ODM development, including ingredient selection, dosage adjustments, delivery formats, flavors, packaging, and commercial supply. Submit your project requirements below to explore customization options, sample development, and manufacturing solutions tailored to your brand and target market.